CORE-009: ANALYTICAL CYTOMETRY SHARED RESOURCE (ACSR) PROJECT SUMMARY / ABSTRACT The Analytical Cytometry Shared Resource (ACSR) provides flow cytometry services for cancer research studies ranging from basic science to clinical trials, and especially for those needing rapid and accurate analysis of biological particles and cells. The ACSR provides OSUCCC members with the ability to obtain viable, sterile and pure populations of cells (>98%) so that they may be individually cloned, assessed for immunological function, and/or examined for specific biochemical properties with minimal manipulations. The ACSR has the following Specific Aims: 1) to provide state-of-the-art equipment and support for high-quality cancer research for OSUCCC members on a fee-for-service basis and to assist investigators with experimental design and assay development; 2) to continuously work with the OSUCCC members to provide substantial technical expertise and training for the use of state-of the-art cytometry instruments so that researchers can have 24 hour access to instruments; and, 3) to introduce OSUCCC members to new instrumentation, technology and methodologies that are being developed at the ACSR through a variety of educational outreach activities. The ACSR is located on the tenth floor of the Biomedical Research Tower (BRT); the BRT and adjacent buildings are home to most OSUCCC investigators. The ACSR is heavily used. Over the past year 5 year period, the ACSR has provided services to 146 OSUCCC members. This past year alone, the ACSR was used by 83 OSUCCC members representing all five OSUCCC scientific programs, and over the last five years it has supported over 55 NCI grants including 2 K awards, 5 P01s, 2 P50s, 1 R00, 34 R01s, 2 R03s, 6 R21s, and 3 U01s. ACSR also supports clinical trials from all five OSUCCC scientific programs. The ACSR has contributed to over 242 cancer related publications over the last grant period, including 27 with an impact factor > 10. During the next grant period, the ACSR is projected to have sufficient capacity to address a growth in OSUCCC members. Part of the ACSR future direction will be to acquire an ImageStream flow cytometer with high resolution microscopy, a BD FACSCanto II flow cytometer and a CyTOF2 Mass Cytometer, and train ACSR personnel and OSUCCC members in their usage. The ACSR leverages extensive institutional support and seeks 28.8% support from CCSG funds. The Analytical Cytometry Core is part of the Analytics Grouping.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA016058-42
Application #
9390847
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
Project End
Budget Start
2017-12-01
Budget End
2018-11-30
Support Year
42
Fiscal Year
2018
Total Cost
Indirect Cost
Name
Ohio State University
Department
Type
DUNS #
832127323
City
Columbus
State
OH
Country
United States
Zip Code
43210
Brasky, Theodore M; Hinton, Alice; Doogan, Nathan J et al. (2018) Characteristics of the Tobacco User Adult Cohort in Urban and Rural Ohio. Tob Regul Sci 4:614-630
Saini, Uksha; Suarez, Adrian A; Naidu, Shan et al. (2018) STAT3/PIAS3 Levels Serve as ""Early Signature"" Genes in the Development of High-Grade Serous Carcinoma from the Fallopian Tube. Cancer Res 78:1739-1750
Olaverria Salavaggione, Gonzalo N; Duggan, Megan C; Carson, William E (2018) Analysis of MLN4924 (pevonedistat) as a potential therapeutic agent in malignant melanoma. Melanoma Res 28:390-397
Jones, Caitlin E; Hammer, Anisha M; Cho, YouJin et al. (2018) Stromal PTEN Regulates Extracellular Matrix Organization in the Mammary Gland. Neoplasia 21:132-145
Fenn, J Daniel; Monsma, Paula C; Brown, Anthony (2018) Axonal neurofilaments exhibit frequent and complex folding behaviors. Cytoskeleton (Hoboken) 75:258-280
Zhang, Lingling; Yu, Jianhua; Wei, Wei (2018) Advance in Targeted Immunotherapy for Graft-Versus-Host Disease. Front Immunol 9:1087
Jasinski, Daniel L; Li, Hui; Guo, Peixuan (2018) The Effect of Size and Shape of RNA Nanoparticles on Biodistribution. Mol Ther 26:784-792
Gordillo, Gayle M (2018) Reply: Urinary Excretion of MicroRNA-126 Is a Biomarker for Hemangioma Proliferation. Plast Reconstr Surg 141:320e
Ott, Christopher J; Federation, Alexander J; Schwartz, Logan S et al. (2018) Enhancer Architecture and Essential Core Regulatory Circuitry of Chronic Lymphocytic Leukemia. Cancer Cell 34:982-995.e7
Willis, William L; Wang, Linan; Wada, Takuma Tsuzuki et al. (2018) The proinflammatory protein HMGB1 is a substrate of transglutaminase-2 and forms high-molecular weight complexes with autoantigens. J Biol Chem 293:8394-8409

Showing the most recent 10 out of 2602 publications